Developing a new drug for spinal cord injury treatment
Official title: NEURESTA DRUG SUBSTANCE MANUFACTURING
Funded at Leidos Biomedical Research, INC. · NIH-11219236 · Data updated 2026-11-12
This study is working on a new drug called NgR(310)Fc [AXER-204] that aims to help people with spinal cord injuries, and it's all about making enough of the drug to test it safely in humans to see if it can really make a difference.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 16, 2019 |
| Project end | September 2, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,363 |
| NIH project number | 75N91019D00024-P00010-759101900140-1 |
| Project ID | NIH-11219236 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced spinal cord injuries or related conditions.
✕Less likely to help
Patients with conditions unrelated to spinal cord injuries may not receive any benefit from this research.
What this research studies
This research focuses on the development of a drug called NgR(310)Fc [AXER-204] aimed at treating spinal cord injuries. The project involves producing this drug in sufficient quantities for use in human clinical trials, ensuring high-quality manufacturing and compliance with regulatory standards. The research team will manage various aspects including technical project management, quality evaluation, and logistics to support the drug's development. Patients with spinal cord injuries may benefit from this innovative treatment if it proves effective in clinical settings.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment option for individuals suffering from spinal cord injuries.
How similar studies have gone: Previous research has shown promise in developing biologics for spinal cord injuries, indicating potential for success in this area.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.